I am a PhD student focused on understanding the mechanisms involved in targeting the hypoxia signalling pathway in myeloid malignancies. My work aims to identify synthetically lethal vulnerabilities ...

What is the study about? IMPORT LOW investigates whether a more targeted type of radiotherapy for people with early breast cancer can reduce side effects without reducing how well the treatment works.

I am a haematology registrar and second-year PhD student. My clinical and research interests are focussed on AML and improving patient outcomes for this disease. The central aim of my work is to ...

Thousands of men with prostate cancer in England will be offered a more precise form of radiotherapy that cuts treatment time by up to 75 per cent, based on the results of a trial led by The Institute ...

A new UK-based study is shedding light on a quiet but consequential problem in cancer research: whether some people have less opportunity than others to participate in clinical trials. The findings ...

The ICR is an exempt charity – reference number X90004. We are also a member institution of the University of London and adhere to regulations as set by the Office for Students and Research England.

PENELOPE B is a phase III international, multicentre, randomised, placebo-controlled, double-blind trial comparing the efficacy and safety of adding palbociclib to standard hormone therapy vs standard ...

IMPORT HIGH is a phase III, prospective, randomised controlled trial to test whether dose escalated, intensity-modulated radiotherapy after conservation surgery for early breast cancer could reduce ...